Search Results 51-60 of 27797 for Two-phase

  1. Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation - Mayo Clinic

    Clinical Trials · Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation · More about research at Mayo Clinic.

  2. A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia - Mayo Clinic

    The study will measure important outcomes including platelet count, stroke, pulmonary embolus (clot to the lungs) and bleeding. Participation eligibility.

  3. A Phase 1B/​2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies (ARTACUS) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. Phase II Trial of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses for Unresectable Stage 2/3 Non-Small Cell Lung Cancer - Mayo Clinic

    This study is being done to study which dose of proton beam therapy (PBT) for unresectable stage 2/3 Non-Small Cell Lung Cancer. Participation eligibility.

  5. Clinical trials - Oncology (Medical)

    The study will be performed in two phases: Phase I will be performed for ... Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of ...

  6. A Phase 1/2 Study to Evaluate MEDI4736 - Mayo Clinic

    This is a multicenter, open-label, first-time-in-human study with a standard 3+3 dose-escalation phase in subjects with advanced solid tumors followed by an ...

  7. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

    The purpose of Phase II part 2 is to compare the Progression-Free Survival (PFS) of TG4001 in combination with avelumab vs avelumab alone in patients with ...

  8. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    The secondary efficacy objective is to assess the effects of natalizumab versus placebo in drug-resistant focal epilepsy on additional measures of seizure ...

  9. A Study of FT 2102 in Participants with Advanced Solid Tumors and Gliomas with an IDH1 Mutation - Mayo Clinic

    The study is divided into two parts: single agent FT-2102 followed by combination therapy. ... Phase 2 investigation of clinical activity in up to 4 cohorts.

  10. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 is shown to block cancer cell epithelial-to-mesenchymal transitions. AXL was identified as a potential therapeutic target in chronic lymphocytic ...